Topical Metronidazole vs Control in Reducing Periodontal Pockets in a Split Mouth Clinical Trial (Perio_topic)
Effect of Topical Metronidazole in Reducing Periodontal Probing Depth: A Split Mouth Clinical Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Salamanca, Spain, 37007
- Dental School of the Faculty of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Periodontal patients with all first premolars suffering from moderate periodontal pockets (>4mm of probing depth)
Exclusion Criteria:
- No patients received antibiotics nor periodontal treatment in the previous 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Metronidazole
These periodontal pockets will be treated with a metronidazole-based gel
|
Scaling and root planing is a deep cleaning below the gumline used to remove plaque and tartar that cover the root in the periodontal pockets.
This intervention is carried out in both control and experimental sites
A gel (experimental: metronidazole VS control: carbopol) is introduced in the recently cleaned periodontal pocket.
The allocation of either experimental or control gel was distributed randomly, being masked both the patient and the clinician.
|
|
Sham Comparator: Carbopole
These deep periodontal pockets (>4mm) are treated with a placebo gel made of carbopol gel
|
Scaling and root planing is a deep cleaning below the gumline used to remove plaque and tartar that cover the root in the periodontal pockets.
This intervention is carried out in both control and experimental sites
A gel (experimental: metronidazole VS control: carbopol) is introduced in the recently cleaned periodontal pocket.
The allocation of either experimental or control gel was distributed randomly, being masked both the patient and the clinician.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Probing depth
Time Frame: Both one month and three months after root scaling
|
Probing depth is assessed at 6 points around the first bicuspids (mesiovestibular, midvestibular, distovestibular, mesiolingual, midlingual, distolingual)
|
Both one month and three months after root scaling
|
|
Mieloperoxidase ng/mL
Time Frame: Both one and three months after root scaling
|
The determination of the quantity of mieloperoxidase ng/mL was assessed from the crevicular fluid of the treated bicuspids
|
Both one and three months after root scaling
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Javier Montero, Main Researcher, University of Salamanca
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- USAL_Nº201700008745
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.